Entacapone Orion European Union - English - EMA (European Medicines Agency)

entacapone orion

orion corporation - entacapone - parkinson disease - anti-parkinson drugs - entacapone is indicated as an adjunct to standard preparations of levodopa / benserazide or levodopa / carbidopa for use in adult patients with parkinson's disease and end-of-dose motor fluctuations, who cannot be stabilised on those combinations.

Levodopa/Carbidopa/Entacapone Orion European Union - English - EMA (European Medicines Agency)

levodopa/carbidopa/entacapone orion

orion corporation - levodopa, carbidopa, entacapone - parkinson disease - nervous system - levodopa/carbidopa/entacapone orion is indicated for the treatment of adult patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa / dopa-decarboxylase (ddc)-inhibitor treatment.

Comtess European Union - English - EMA (European Medicines Agency)

comtess

orion corporation - entacapone - parkinson disease - anti-parkinson drugs - entacapone is indicated as an adjunct to standard preparations of levodopa / benserazide or levodopa / carbidopa for use in patients with parkinson's disease and end-of-dose motor fluctuations, who cannot be stabilised on those combinations.

Fareston European Union - English - EMA (European Medicines Agency)

fareston

orion corporation - toremifene - breast neoplasms - endocrine therapy - first line hormone treatment of hormone-dependent metastatic breast cancer in postmenopausal patients.fareston is not recommended for patients with estrogen receptor negative tumours.

Carbidopa/Levodopa Orion 12.5 mg/50 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

carbidopa/levodopa orion 12.5 mg/50 mg tablets

orion corporation - carbidopa monohydrate; levodopa - tablet - levodopa and decarboxylase inhibitor

Carbidopa/Levodopa Orion 25 mg/100 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

carbidopa/levodopa orion 25 mg/100 mg tablets

orion corporation - carbidopa monohydrate; levodopa - tablet - levodopa and decarboxylase inhibitor

Bufomix Easyhaler, 160 micrograms/4.5 micrograms/inhalation, inhalation powder Malta - English - Medicines Authority

bufomix easyhaler, 160 micrograms/4.5 micrograms/inhalation, inhalation powder

orion corporation orionintie 1, fi-02200 espoo, finland - formoterol fumarate, dihydrate, budesonide - inhalation powder - formoterol fumarate dihydrate 4.5 µg budesonide 160 µg - drugs for obstructive airway diseases